Objectives The widespread use of proton pump inhibitors (PPIs) raised concerns on the safety of long-term use of these drugs. Community pharmacists have great responsibility of educating patients on ...

E-mail: andrebaldoni@ufsj.edu.br. Information about proton pump inhibitors (PPIs) available in the leaflets on the Food and Drug Administration (FDA) website table_chartTABLE I Information about ...

Objective To determine whether proton pump inhibitors (PPIs) are associated with an increased ... of colorectal cancer (identified using Read codes, online supplemental table 3), 1 year after ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of ... of gastric cancer (identified using Read codes (online supplemental table 3), 1 year after ...

Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...

Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with moderate-to-severe GERD and are widely prescribed to pregnant women. However, safety data about the use of ...

Higher PPI dosages improve outcomes in those with gastroesophageal disease, but it is unclear whether twice-daily dosing is more effective.

Expert Rev Clin Pharmacol. 2013;6(4):443-451.

Unconventional Computing Laboratory, University of the West of England, Bristol BS16 1QY, U.K.